ReviewAnnals of translational medicine2015
International consensus on the management of intraductal papillary mucinous neoplasm of the pancreas.
Review in Annals of translational medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 46 citations in OpenAlex.
- Endoscopic-guided chemoablation of an inoperable main-duct intraductal papillary mucinous neoplasm.Journal of surgical case reports · 2026Article
- Intraductal papillary mucinous neoplasm with gastric penetration diagnosed using endoscopic imaging and aspiration cytology.Endoscopy · 2025Article
- Branch Duct IPMN-Associated Acute Pancreatitis in a Large Single-Center Cohort Study.Diagnostics (Basel, Switzerland) · 2025Article
- MRI features of intraductal papillary mucinous neoplasm of the bile ducts, "The myth about the cyst": A systematic review.European journal of radiology open · 2023Review
- Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Challenging Diagnosis.Diagnostics (Basel, Switzerland) · 2023Review
- Pancreatic Neoplasms: CT Evaluation of the Uncommon Presentations of Common Lesions and Common Presentations of the Uncommon Lesions!The Indian journal of radiology & imaging · 2022Review
- Favorable response after radiation therapy for intraductal papillary mucinous neoplasms manifesting as acute recurrent pancreatitis: A case report.World journal of clinical cases · 2022Article
- Peak density of immature nerve cells occurs with high-grade dysplasia in intraductal papillary mucinous neoplasms of the pancreas.The Journal of pathology · 2022Article
- Diagnostic and Therapeutic Indications for Endoscopic Ultrasound (EUS) in Patients with Pancreatic and Biliary Disease-Novel Interventional Procedures.Current oncology (Toronto, Ont.) · 2022Review
- Pancreatic intraductal papillary mucinous neoplasms: Current diagnosis and management.World journal of gastrointestinal oncology · 2021Review
- Validation of Serum Biomarkers That Complement CA19-9 in Detecting Early Pancreatic Cancer Using Electrochemiluminescent-Based Multiplex Immunoassays.Biomedicines · 2021Article
- Branch Duct - IPMN and PanIN, in IgG4-Autoimmune pancreatitis: A case report.Clinical case reports · 2020Article
- CT imaging comparison between intraductal papillary neoplasms of the bile duct and papillary cholangiocarcinomas.European radiology · 2019Article
- Evaluation of the International Consensus Guidelines for the Surgical Resection of Intraductal Papillary Mucinous Neoplasms.Digestive diseases and sciences · 2018Article
- Review
- Cross-sectional prevalence of pancreatic cystic lesions in patients with acromegaly, a single-center experience.Pituitary · 2017Article
- Imaging Pancreatic Cysts with CT and MRI.Digestive diseases and sciences · 2017Review
- Dynamics of Fukuoka Criteria and Patient Management in Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMNs) During Follow-Up.Medical science monitor : international medical journal of experimental and clinical research · 2017Article
- Immunobiology and immunosurveillance in patients with intraductal papillary mucinous neoplasms (IPMNs), premalignant precursors of pancreatic adenocarcinomas.Cancer immunology, immunotherapy : CII · 2016Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
International consensus guidelines for the management of intraductal papillary mucinous neoplasm (IPMN) of the pancreas revised in 2012 (Fukuoka consensus) seem to be accepted well worldwide. Division of various factors to predict malignant transformation into two categories, i.e., "high-risk stigmata" and "worrisome features", is also accepted as practically useful for stratifying the risk factors. Our current interest resides in the development of noninvasive and/or invasive pancreatic cancer in areas of the pancreas distinct from IPMN. Invasive pancreatic cancers derived from and concomitant with IPMN should be distinguished to clarify the incidence of each entity, although some more definitive method for differentiation has to be devised in some cases where histological distinction is obscure. IPMN is a clue to early detection of pancreatic cancer. The optimal surveillance protocol for IPMN on observation should be determined in consideration of both of these different pancreatic cancers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.